Literature DB >> 27221269

An update on the diagnosis and treatment of Parkinson disease.

Philippe Rizek1, Niraj Kumar1, Mandar S Jog2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27221269      PMCID： PMC5088077          DOI： 10.1503/cmaj.151179

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  115 in total

Review 1.  Epidemiology, diagnosis and differential diagnosis in Parkinson's disease tremor.

Authors:  Christian R Baumann
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Pharmacological treatment of Parkinson disease: a review.

Authors:  Barbara S Connolly; Anthony E Lang
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

Review 3.  Motor response complications and the function of striatal efferent systems.

Authors:  T N Chase; M M Mouradian; T M Engber
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

Review 4.  Evidence-based treatment of voice and speech disorders in Parkinson disease.

Authors:  Leslie A Mahler; Lorraine O Ramig; Cynthia Fox
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2015-06       Impact factor: 2.064

5.  Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.

Authors:  Paolo Solla; Alfonso Fasano; Antonino Cannas; Cesare Salvatore Mulas; Maria Giovanna Marrosu; Anthony E Lang; Francesco Marrosu
Journal:  Parkinsonism Relat Disord       Date:  2015-06-10       Impact factor: 4.891

6.  Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

Authors:  F J Vingerhoets; M Schulzer; D B Calne; B J Snow
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

7.  Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.

Authors:  A Schrag; Y Ben-Shlomo; R Brown; C D Marsden; N Quinn
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

8.  Handwriting as an objective tool for Parkinson's disease diagnosis.

Authors:  Sara Rosenblum; Margalit Samuel; Sharon Zlotnik; Ilana Erikh; Ilana Schlesinger
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

Review 9.  Modeling Lewy pathology propagation in Parkinson's disease.

Authors:  Kelvin C Luk; Virginia M-Y Lee
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

10.  REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease.

Authors:  Michal Rolinski; Konrad Szewczyk-Krolikowski; Paul R Tomlinson; Kannan Nithi; Kevin Talbot; Yoav Ben-Shlomo; Michele Tm Hu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-01       Impact factor: 10.154
View more
  58 in total

Review 1.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

2.  6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson's Model.

Authors:  Xiufeng Wang; Heng Zhai; Fang Wang
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

3.  Acanthopanax senticosus Protects Structure and Function of Mesencephalic Mitochondria in A Mouse Model of Parkinson's Disease.

Authors:  Shu-Min Liu; Xu-Zhao Li; Shuai-Nan Zhang; Zhi-Ming Yang; Ke-Xin Wang; Fang Lu; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Chin J Integr Med       Date:  2018-08-08       Impact factor: 1.978

4.  Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.

Authors:  Anas Arab; Jana Ruda-Kucerova; Alzbeta Minsterova; Eva Drazanova; Nikoletta Szabó; Zenon Starcuk; Irena Rektorova; Amit Khairnar
Journal:  Neurotox Res       Date:  2019-06-18       Impact factor: 3.911

5.  Neuro4PD: An Initial Neurorobotics Model of Parkinson's Disease.

Authors:  Jhielson M Pimentel; Renan C Moioli; Mariana F P de Araujo; Caetano M Ranieri; Roseli A F Romero; Frank Broz; Patricia A Vargas
Journal:  Front Neurorobot       Date:  2021-07-01       Impact factor: 2.650

6.  iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.

Authors:  A H Laperle; S Sances; N Yucer; V J Dardov; V J Garcia; R Ho; A N Fulton; M R Jones; K M Roxas; P Avalos; D West; M G Banuelos; Z Shu; R Murali; N T Maidment; J E Van Eyk; M Tagliati; C N Svendsen
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

Review 7.  Role of Liver Growth Factor (LGF) in Parkinson's Disease: Molecular Insights and Therapeutic Opportunities.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

8.  Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [123I]FP-CIT SPECT/CT Brain Imaging.

Authors:  Jeanne P Vu; Ghiam Yamin; Zabrina Reyes; Alex Shin; Alexander Young; Irene Litvan; Pengtao Xie; Sebastian Obrzut
Journal:  Tomography       Date:  2021-03-26

9.  Liposomal Form of L-Dopa and SH-Sy5y Cell-Derived Exosomes Modulate the Tyrosine Hydroxylase/Dopamine Receptor D2 Signaling Pathway in Parkinson's Rat Models.

Authors:  Parastoo Zarrin; Mahmood Dehghani Ashkezari; Seyed Morteza Seifati
Journal:  J Mol Neurosci       Date:  2021-06-14       Impact factor: 3.444

10.  Does antiretroviral therapy alter the course of Parkinson's disease in people living with HIV?

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Anand Moodley
Journal:  J Neurovirol       Date:  2021-08-05       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.